Jane He is a General Partner at YZi Labs and was previously an analyst at Barclays and COO of Apeiron Capital. Since graduating from Stanford GSB, Jane has a strong track record in biotech and medtech, actively pursuing disruptive opportunities at the intersection of AI and biotech. Her expertise spans cancer therapies, gene editing, metabolic treatments, and AI-driven biotech solutions, bringing a visionary approach to investing.